Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medstar Health Research Institute
Minimally invasive surgical procedures using mesh have rapidly developed in the field of pelvic floor reconstruction. Unfortunately, safety and efficacy data have lagged behind the technical advancements. No randomized controlled trials of different vaginal apical suspension procedures have been reported. The use of synthetic vaginal mesh has evolved due to the 20-30% recurrence rate for conventional pelvic reconstructive surgeries. This trial will examine synthetic monofilament polypropylene mesh use in vaginal reconstructive surgery for vaginal Stage II-IV prolapse.
Age
21–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Woman \> 21 yrs
Stage II-IV vaginal prolapse
Desires vaginal reconstructive surgery
Able to complete study questionnaires and assessments
Uterus \< 12 weeks size
Available for 12 months follow-up
You may not be if
Medical contraindications, e.g. current urinary tract, vaginal or pelvic infection, history of pelvic irradiation, history of lower urinary tract malignancy, chronic steroid use or a compromised immune system.
Current intermittent catheterization.
Pregnancy or desire for future fertility.
Presence of an adnexal mass.
Shortened vagina or other known Mullerian anomaly (e.g. uterine didelphys).
Other laparoscopic or abdominal/pelvic surgery in the past 3 months.
Known neurologic or medical condition affecting bladder function, e.g. Multiple Sclerosis, spinal cord injury.
Need for concomitant surgery requiring an abdominal incision.
\< 12 months post-partum.
Non-english speaking
Clareo Health | Efficacy Study of Vaginal Mesh for Prolapse
